Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine + dexmedetomidine versus remifentanil + dexmedetomidine for monitored anesthesia care during HIFU treatment of uterine fibroids
ChiCTR2500096909Phase 4Not yet recruiting
- Sponsor
- Zhongshan People's Hospital
- Start
- Feb 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dezocine, dexmedetomidine and remifentanil in Fibromyoma (LM) (2 arms), sponsored by Zhongshan People's Hospital. Primary endpoints: Pain Numeric Rating Scale score, Ramsay Sedation Scale score and 2 more. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
dezocinedexmedetomidineremifentanil
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2500096909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096909.